Zydus Lifesciences Limited (ZYDUSLIFE.NS) NSE

1,070.50

-7.8(-0.72%)

Updated at June 03 12:36PM

Currency In INR

Valuation

Market Cap876.59B
Enterprise Value987.39B
P/E Ratio21.29
PEG Ratio1.87
Price/Sales Ratio3.95
Price/Book Ratio3.96
Enterprise/Revenue4.36
Enterprise/EBITDA15.08

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.19
Operating Margin0.29

Management Effectiveness

Return On Assets0.1
Return On Equity0.2

Income Statement

Revenue271.48B
Revenue/Share269.88
Gross Profit140.3B
EBITDA71.95B
Net Income50.4B
Diluted EPS50.09

Balance Sheet

Total Cash71.92B
Total Cash/Share71.5
Total Debt124.96B
Total Debt/Equity0.46
Current Ratio1.27
Book Value Per Share294.08

Price History

52-Week Change15.16
52-Week High1,115.5
52-Week Low835.5
Moving Average 50 Days950.53
Moving Average 200 Days944.35

Statistics

Average Volume1.32M
Shares Outstanding1.01B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate11
Trailing Annual Dividend Yield1.03
Payout Ratio0.22
Last Split Factor5:1
Last Split DateOctober 06, 2015